tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BDRX Stock Latest News

Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
Company AnnouncementsBiodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
23h ago
6K
BDRX
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
PremiumThe Fly
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
24h ago
BDRX
Biodexa Pharmaceuticals supports Life’s a Polyp Foundation
PremiumThe Fly
Biodexa Pharmaceuticals supports Life’s a Polyp Foundation
10d ago
BDRX
Biodexa Licenses Otsuka’s Phase 1‑Ready Molecular Glue MTX240 for GIST
PremiumCompany Announcements
Biodexa Licenses Otsuka’s Phase 1‑Ready Molecular Glue MTX240 for GIST
1M ago
6K
BDRX
Biodexa Pharmaceuticals announces exclusive license with Otsuka Pharmaceutical
PremiumThe Fly
Biodexa Pharmaceuticals announces exclusive license with Otsuka Pharmaceutical
1M ago
BDRX
Biodexa Pharmaceuticals Names Fiona Sharp CFO and Board Director
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Names Fiona Sharp CFO and Board Director
2M ago
6K
BDRX
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
Premium
Company Announcements
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director
2M ago
6K
BDRX
Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
Premium
The Fly
Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary
2M ago
BDRX
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
PremiumCompany Announcements
Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline
3M ago
6K
BDRX
Biodexa Pharmaceuticals prices 157,000 units at $3.28 in public offering
PremiumThe Fly
Biodexa Pharmaceuticals prices 157,000 units at $3.28 in public offering
3M ago
BDRX
Biodexa Pharmaceuticals PLC-ADR trading resumes
PremiumThe Fly
Biodexa Pharmaceuticals PLC-ADR trading resumes
3M ago
BDRX
Biodexa Pharmaceuticals PLC-ADR trading halted, volatility trading pause
PremiumThe Fly
Biodexa Pharmaceuticals PLC-ADR trading halted, volatility trading pause
3M ago
BDRX
Biodexa announces enrollment of first European patients in Phase 3 Serenta trial
PremiumThe FlyBiodexa announces enrollment of first European patients in Phase 3 Serenta trial
4M ago
BDRX
Biodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
Premium
The Fly
Biodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
4M ago
BDRX
Biodexa Pharmaceuticals files to sell 3.38M units
Premium
The Fly
Biodexa Pharmaceuticals files to sell 3.38M units
4M ago
BDRX
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
PremiumCompany Announcements
Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
5M ago
6K
BDRX
Biodexa announces approval of CTA by EMA of Phase 3 trial in FAP
PremiumThe Fly
Biodexa announces approval of CTA by EMA of Phase 3 trial in FAP
5M ago
BDRX
Biodexa Pharmaceuticals’ Phase 3 Trial Update: A Potential Breakthrough in FAP Treatment
PremiumCompany Announcements
Biodexa Pharmaceuticals’ Phase 3 Trial Update: A Potential Breakthrough in FAP Treatment
5M ago
BDRX
Biodexa Pharmaceuticals files $100M mixed securities shelf
PremiumThe Fly
Biodexa Pharmaceuticals files $100M mixed securities shelf
6M ago
BDRX
Biodexa Pharmaceuticals Advances Serenta Trial and Secures Financial Backing
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Advances Serenta Trial and Secures Financial Backing
6M ago
6K
BDRX
Biodexa says requirement for financing represents ‘material uncertainty’
Premium
The Fly
Biodexa says requirement for financing represents ‘material uncertainty’
6M ago
BDRX
Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
Premium
The Fly
Biodexa Pharmaceuticals reports 1H EPS (GBP0.0002) vs. (GBP0.001) last year
6M ago
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >